STOCK TITAN

BAYER (BAYRY) Stock News, Mar-Apr 2023

BAYRY OTC

BAYER AG S/ADR (BAYRY) news covers developments at Bayer AG, a global life science enterprise active in health care and nutrition. Company communications highlight updates across its Pharmaceuticals Division, radiology business and crop science activities, giving investors and observers insight into how Bayer advances its pipeline and product portfolio.

Recent pharmaceutical news emphasizes growth in oncology, cardiology, neurology, immunology and women’s health. Examples include updates on asundexian for secondary stroke prevention, finerenone (Kerendia) in cardiovascular-kidney-metabolic conditions, and oncology assets such as Nubeqa for prostate cancer, Hyrnuo for HER2-mutant non-small cell lung cancer, and Xofigo for metastatic castration-resistant prostate cancer with bone metastases. Bayer also reports on Lynkuet, a hormone-free treatment for moderate to severe hot flashes due to menopause, and a Phase III SUNFLOWER study evaluating Mirena for nonatypical endometrial hyperplasia.

News items also describe Bayer’s work in radiology and molecular imaging, including the low-dose MRI contrast agent gadoquatrane and the acquisition of investigational tracers AT-01 and AT-05 for diagnosing cardiac amyloidosis. Additional coverage highlights cell and gene therapy programs for Parkinson’s disease and ophthalmic conditions, as well as collaborations such as the agreement with Soufflé Therapeutics to develop a heart-targeted siRNA therapy for a form of dilated cardiomyopathy.

On the agriculture side, Bayer Crop Science Canada announcements feature launches like Sivanto Energy for flea beetle control in canola and EverGol Rise for pulse disease control. Together, these updates illustrate how Bayer seeks to execute its mission “Health for all, Hunger for none” through pharmaceutical innovation, diagnostic imaging advances and crop protection solutions.

Rhea-AI Summary

The global market for Agricultural Biotechnology is projected to grow from US$43.3 Billion in 2022 to US$88.9 Billion by 2030, reflecting a CAGR of 9.4%. The U.S. market is estimated at US$12.7 Billion, while China is expected to reach US$15.2 Billion by the same period, growing at an 8.7% CAGR. Notably, the Molecular Diagnostics segment is projected to achieve a 10.8% CAGR with an expected value of US$35.6 Billion. The report highlights significant growth in Tissue Culture at 10.1% CAGR and features key competitors including Bayer CropScience, BASF, and Syngenta. Special coverage for 2023 includes insights on the impacts of global inflation, the Russia-Ukraine conflict, and supply chain disruptions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.42%
Tags
none
-
Rhea-AI Summary

GreenLab, Inc. announces the appointment of Ryan Schon as the new Chief Operating Officer effective April 6, 2023. Schon will spearhead the launch of the company’s innovative GreenLab Vector Technology (GVT) platform, aimed at revolutionizing protein production in biomanufacturing.

Schon, a veteran with 25 years of experience in the seed industry, including key positions at Monsanto and Corteva, brings valuable expertise in strategy and management. His leadership is expected to enhance GreenLab's capacity to produce novel proteins while addressing crucial scalability and regulatory challenges.

The company currently has three transformative enzymes in production and is focused on commercializing the sweet recombinant protein brazzein. GreenLab aims to partner with various industries to optimize sustainable protein manufacturing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.15%
Tags
none
-
Rhea-AI Summary

The global Phosphoric Acid (Pharmaceutical Grade) market reached approximately 2,000,000 tonnes in 2021, with a projected growth rate of 5.16% CAGR until 2030, potentially reaching 3,000,000 tonnes. The primary driver is the Oral Care industry, utilizing phosphoric acid in dental bonding. The market is dominated by the Asia Pacific region, accounting for 45% of consumption, with China and Taiwan as key producers. The report segments the market by end-use, sales channel, and region, highlighting the significant role of phosphoric acid in dentistry and medication.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.49%
Tags
none
Rhea-AI Summary

Genective, a joint venture between Limagrain and KWS, announces the appointment of Thomas Clark, Ph.D., as VP of Research and CSO, succeeding Francois Torney, Ph.D. Clark brings over 30 years of experience in agricultural product development, previously holding leadership roles at Provivi and Monsanto. His expertise is expected to strengthen Genective's capabilities in transgenic traits, particularly insect control technologies. The change in leadership is aligned with Genective's aim to enhance its research engine and meet increasing market demands sustainably.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.44%
Tags
none
-
Rhea-AI Summary

Deiya Pernas, former Deputy Chief Investment Officer of The Bahnsen Group, has announced the launch of Pernas Research, a new stock research firm aimed at discerning investors. The firm seeks to fill a gap in quality stock research amidst a market saturated with low-quality content. Pernas Research focuses on attractively-priced companies, emphasizing those with sustainable cash flows or a path to recovery. Deiya, who helped grow The Bahnsen Group's assets from $500 million to $3.5 billion, aims to set a new standard in accessible investment research.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.93%
Tags
none
-
Rhea-AI Summary

Neo4j has expanded its strategic partnership with Google Cloud by introducing a native integration with Google Cloud's BigQuery. This integration allows users to seamlessly combine SQL analysis with graph-native data science and machine learning. Customers can now conduct deep graph analysis and move data models between BigQuery and Neo4j Graph Data Science easily. This partnership aims to enhance analytical capabilities and decision-making by utilizing graph technology, projected to be crucial in 80% of data innovations by 2025 according to Gartner. The integration is currently in private preview, with general availability expected in August 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.77%
Tags
partnership
Rhea-AI Summary

The global crop protection chemicals market was valued at US$ 88.0 Billion in 2022, projected to grow to US$ 116.5 Billion by 2028, at a CAGR of 4.79%.

Key players include BASF, Corteva Agriscience, and Bayer Cropscience. The market is segmented by product type (herbicides, insecticides, fungicides), with herbicides currently dominating. Other categorizations include origin (synthetic, natural), crop type (cereal, fruits, oilseeds), form (liquid, solid), and application methods (foliar spray, seed treatment). As global population pressures increase, the need for effective crop protection chemicals will be critical for maintaining agricultural productivity and food security.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.59%
Tags
none
-
Rhea-AI Summary

The Agrochemicals Market is anticipated to grow from USD 235.2 billion in 2023 to USD 282.2 billion by 2028, reflecting a CAGR of 3.7%.

Key drivers include favourable government policies and rising demand for organic products. The adoption of new technologies and an increase in agricultural exports play significant roles in market expansion.

South America, particularly Brazil and Argentina, is projected to significantly contribute to this growth, reaching USD 73.2 billion.

Major players include Bayer AG, Syngenta, and BASF.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.13%
Tags
none
-
Rhea-AI Summary

The report titled 'Global Drought Resistant Crops Market By Crop Type, By Distribution Channel, By Region, Competition Opportunities & Forecast, 2027' highlights significant growth in the global drought-resistant crops market expected from 2023 to 2027. This growth is driven by rising food demands and the need for crops that can adapt to water-scarce conditions. The market is segmented by crop type, with corn/maize likely to dominate. North America is anticipated to retain a major market share, bolstered by technological advancements in genetically modified crops. Major players include Bayer CropScience, Syngenta, and Monsanto, among others.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags
none
Rhea-AI Summary

MP Materials Corp. (NYSE: MP) has appointed Arnold W. Donald, former CEO of Carnival Corporation, to its board of directors. His extensive experience in corporate leadership and strategic planning is expected to enhance the company's operations at a pivotal time. Mr. Donald emphasizes the potential for MP Materials to diversify supply chains essential to the global economy through innovation and sustainability.

Under Donald’s leadership, Carnival achieved significant profitability and successfully navigated fleet restoration post-COVID-19. MP Materials is a key U.S. producer of rare earth materials, crucial for electrification and advanced technologies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.04%
Tags
none

FAQ

What is the current stock price of BAYER (BAYRY)?

BAYER (BAYRY) last closed at $12.3.

What is the market cap of BAYER (BAYRY)?

The market cap of BAYER (BAYRY) is approximately $48.3B.